303 related articles for article (PubMed ID: 28107610)
1. Tonsil-derived mesenchymal stem cells (T-MSCs) prevent Th17-mediated autoimmune response via regulation of the programmed death-1/programmed death ligand-1 (PD-1/PD-L1) pathway.
Kim JY; Park M; Kim YH; Ryu KH; Lee KH; Cho KA; Woo SY
J Tissue Eng Regen Med; 2018 Feb; 12(2):e1022-e1033. PubMed ID: 28107610
[TBL] [Abstract][Full Text] [Related]
2. Poly I:C primes the suppressive function of human palatine tonsil-derived MSCs against Th17 differentiation by increasing PD-L1 expression.
Cho KA; Park M; Kim YH; Ryu KH; Woo SY
Immunobiology; 2017 Feb; 222(2):394-398. PubMed ID: 27594385
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway.
Luz-Crawford P; Noël D; Fernandez X; Khoury M; Figueroa F; Carrión F; Jorgensen C; Djouad F
PLoS One; 2012; 7(9):e45272. PubMed ID: 23028899
[TBL] [Abstract][Full Text] [Related]
4. Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1-high T cells.
Kim JH; Choi YJ; Lee BH; Song MY; Ban CY; Kim J; Park J; Kim SE; Kim TG; Park SH; Kim HP; Sung YC; Kim SC; Shin EC
J Allergy Clin Immunol; 2016 May; 137(5):1466-1476.e3. PubMed ID: 26824999
[TBL] [Abstract][Full Text] [Related]
5. Human adipose-derived mesenchymal stem cells prevent type 1 diabetes induced by immune checkpoint blockade.
Kawada-Horitani E; Kita S; Okita T; Nakamura Y; Nishida H; Honma Y; Fukuda S; Tsugawa-Shimizu Y; Kozawa J; Sakaue T; Kawachi Y; Fujishima Y; Nishizawa H; Azuma M; Maeda N; Shimomura I
Diabetologia; 2022 Jul; 65(7):1185-1197. PubMed ID: 35511238
[TBL] [Abstract][Full Text] [Related]
6. Non-thermal atmospheric plasma ameliorates imiquimod-induced psoriasis-like skin inflammation in mice through inhibition of immune responses and up-regulation of PD-L1 expression.
Lee YS; Lee MH; Kim HJ; Won HR; Kim CH
Sci Rep; 2017 Nov; 7(1):15564. PubMed ID: 29138509
[TBL] [Abstract][Full Text] [Related]
7. Differential Involvement of Programmed Cell Death Ligands in Skin Immune Responses.
Tanaka R; Ichimura Y; Kubota N; Saito A; Nakamura Y; Ishitsuka Y; Watanabe R; Fujisawa Y; Mizuno S; Takahashi S; Fujimoto M; Okiyama N
J Invest Dermatol; 2022 Jan; 142(1):145-154.e8. PubMed ID: 34310947
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal Stromal Cell Secretion of Programmed Death-1 Ligands Regulates T Cell Mediated Immunosuppression.
Davies LC; Heldring N; Kadri N; Le Blanc K
Stem Cells; 2017 Mar; 35(3):766-776. PubMed ID: 27671847
[TBL] [Abstract][Full Text] [Related]
9. Programmed Death Ligand 1 Plays a Neuroprotective Role in Experimental Autoimmune Neuritis by Controlling Peripheral Nervous System Inflammation of Rats.
Ding Y; Han R; Jiang W; Xiao J; Liu H; Chen X; Li X; Hao J
J Immunol; 2016 Nov; 197(10):3831-3840. PubMed ID: 27798164
[TBL] [Abstract][Full Text] [Related]
10. Effect of baricitinib in regulating programmed death 1 and ligand programmed cell death ligand 1 through JAK/STAT pathway in psoriasis.
Deepak HB; Prince SE; Deshpande P
Indian J Pharmacol; 2022; 54(3):183-193. PubMed ID: 35848689
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow-derived mesenchymal stem cells promote cell proliferation of multiple myeloma through inhibiting T cell immune responses via PD-1/PD-L1 pathway.
Chen D; Tang P; Liu L; Wang F; Xing H; Sun L; Jiang Z
Cell Cycle; 2018; 17(7):858-867. PubMed ID: 29493401
[TBL] [Abstract][Full Text] [Related]
12. Human placenta-derived mesenchymal stem cells ameliorate diabetic kidney disease by modulating the T helper 17 cell/ regulatory T-cell balance through the programmed death 1 / programmed death-ligand 1 pathway.
Wang J; Liu H; Yue G; Deng Y; Cai W; Xu J
Diabetes Obes Metab; 2024 Jan; 26(1):32-45. PubMed ID: 37722965
[TBL] [Abstract][Full Text] [Related]
13. Programmed death 1/programmed cell death-ligand 1 pathway participates in gastric surgery-induced imbalance of T-helper 17/regulatory T cells in mice.
Dong L; Zheng X; Wang K; Wang G; Zou H
J Trauma Acute Care Surg; 2018 Sep; 85(3):549-559. PubMed ID: 29554041
[TBL] [Abstract][Full Text] [Related]
14. Conditioned Medium from Human Tonsil-Derived Mesenchymal Stem Cells Enhances Bone Marrow Engraftment via Endothelial Cell Restoration by Pleiotrophin.
Kim YH; Cho KA; Lee HJ; Park M; Shin SJ; Park JW; Woo SY; Ryu KH
Cells; 2020 Jan; 9(1):. PubMed ID: 31952360
[TBL] [Abstract][Full Text] [Related]
15. MiR-21 Participates in the PD-1/PD-L1 Pathway-Mediated Imbalance of Th17/Treg Cells in Patients After Gastric Cancer Resection.
Zheng X; Dong L; Wang K; Zou H; Zhao S; Wang Y; Wang G
Ann Surg Oncol; 2019 Mar; 26(3):884-893. PubMed ID: 30565043
[TBL] [Abstract][Full Text] [Related]
16. N-glycosylation controls inflammatory licensing-triggered PD-L1 upregulation in human mesenchymal stromal cells.
Strauch V; Saul D; Berisha M; Mackensen A; Mougiakakos D; Jitschin R
Stem Cells; 2020 Aug; 38(8):986-993. PubMed ID: 32346937
[TBL] [Abstract][Full Text] [Related]
17. Stem cells from exfoliated deciduous teeth transplantation ameliorates Sjögren's syndrome by secreting soluble PD-L1.
Yang N; Liu X; Chen X; Yu S; Yang W; Liu Y
J Leukoc Biol; 2022 May; 111(5):1043-1055. PubMed ID: 34622984
[TBL] [Abstract][Full Text] [Related]
18. PD-L1 overexpression conveys tolerance of mesenchymal stem cell-derived cardiomyocyte-like cells in an allogeneic mouse model.
Mardomi A; Limoni SK; Rahbarghazi R; Mohammadi N; Khorashadizadeh M; Ranjbaran H; Nataj HH; Jafari N; Hasani B; Abediankenari S
J Cell Physiol; 2021 Sep; 236(9):6328-6343. PubMed ID: 33507552
[TBL] [Abstract][Full Text] [Related]
19. The Role of PD-L1 on Langerhans Cells in the Regulation of Psoriasis.
Tanaka R; Ichimura Y; Kubota N; Konishi R; Nakamura Y; Mizuno S; Takahashi S; Fujimoto M; Nomura T; Okiyama N
J Invest Dermatol; 2022 Dec; 142(12):3167-3174.e9. PubMed ID: 35803322
[TBL] [Abstract][Full Text] [Related]
20. Inducible indoleamine 2,3-dioxygenase 1 and programmed death ligand 1 expression as the potency marker for mesenchymal stromal cells.
Guan Q; Li Y; Shpiruk T; Bhagwat S; Wall DA
Cytotherapy; 2018 May; 20(5):639-649. PubMed ID: 29548707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]